Screener
Geron GERN Chemistry, manufacturing, and control expenses — R&D
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Geron in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Geron’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:41 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886744-26-000037
| (in millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of goods sold | 9.2 | 1.2 | 10.9 | 2.4 |
| Research and development | ||||
| Research and clinical expenses | 11.1 | 19.8 | 24.1 | 33.5 |
| Chemistry, manufacturing, and control expenses | 9.5 | 1.9 | 10.1 | 3.3 |
| Restructuring charges | (0.1) | — | (0.3) | — |
| Selling, general and administrative | ||||
| Commercial expenses | 21.6 | 18.8 | 38.6 | 36.5 |
| Restructuring charges | (0.1) | — | (0.3) | — |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Geron's chemistry, manufacturing, and control expenses — R&D?
- Geron (GERN) reported chemistry, manufacturing, and control expenses — R&D of $9.5M in Q2 2026.
- How has Geron's chemistry, manufacturing, and control expenses — R&D changed year-over-year?
- Geron's chemistry, manufacturing, and control expenses — R&D increased by 400.0% year-over-year, from $1.9M to $9.5M.
- What does chemistry, manufacturing, and control expenses — R&D mean?
- This metric represents the costs associated with the development, scale-up, and quality assurance of manufacturing processes for clinical-stage drug candidates. It encompasses activities required to ensure pharmaceutical products meet regulatory standards for purity, stability, and consistency during the research and development phase. Monitoring these expenses provides insight into the company's investment in supply chain readiness and the technical feasibility of transitioning drug candidates from clinical trials to commercial production.
Ask your AI about Geron's chemistry, manufacturing, and control expenses — r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude